Characterization of autologous tumor‐specific T‐helper 2 cells in tumor‐infiltrating lymphocytes from a patient with metastatic melanoma
Authors:
- 1 August 1994
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 58 (3) , 317-323
Abstract
Human autologous tumor‐specific T‐helper 2 (Th2) cells were investigated in melanoma tumor‐infiltrating lymphocytes (TILs). Both a CD4+ T‐cell line and its 5 potential T‐cell clones established from TILs of a patient with metastatic melanoma produced significant levels of IL‐4, IL‐6, IL‐10 and granulocyte‐macrophage colony‐stimulating factor (GM‐CSF) in response to autologous, but not any of 12 allogeneic, melanoma cell lines. They also produced IL‐3 and IL‐8 but not IL‐2, IFN‐γ, TNF‐α or TNF‐β in response to autologous tumor cells. Furthermore, they showed autologous melanoma‐specific cytotoxicity only in an 18‐hr 51Cr‐release assay. Specific IL‐4, IL‐6 or IL‐10 production by the CD4+ M73 T‐cell line and its clone was inhibited by anti‐class 11 DR (but not anti‐class 1) MAb, whereas their specific cytotoxicity was inhibited by anti‐class 1 (but not anti‐class 11) MAb. Anti‐CD3 and ‐CD4 MAb (but not anti‐CD8) abrogated both IL‐4, IL6 and IL‐10 production and cytotoxicity, while anti‐IL‐4 antibody did not inhibit cytotoxicity. CD4+ potential T‐cell clones, but not CD8+ clones, that were established from freshly isolated TILs without in vitro sensitization by autologous tumor cells also produced IL‐4, IL‐6 and IL‐10 but not IFN‐γ or tumor necrosis factor (TNF)α in an autologous tumor‐specific fashion. These Th2 cells were neither reactive to EBV‐B cells nor suppressive against CD8+ T‐cell clones. PMA and PHA stimulated these potential T‐cell clones, regardless of their specific lymphokine production, to produce IL‐3, IL‐4, IL‐6, IL‐8, IL‐10, GM‐CSF, TNFα and IFN‐γ. Our results demonstrate the presence of autologous tumor‐specific Th2 cells at the melanoma sites.Keywords
This publication has 34 references indexed in Scilit:
- Distribution of autologous tumor‐specific cytotoxic T lymphocytes in human metastatic melanomaInternational Journal of Cancer, 1992
- Human renal‐cell carcinoma cells are able to activate natural killer cellsInternational Journal of Cancer, 1992
- TH2 cells in systemic autoimmunity: insights from allogeneic diseases and chemically-induced autoimmunityImmunology Today, 1991
- Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones.Journal of Experimental Medicine, 1989
- Autologous tumor-specific cytotoxic T lymphocytes in the infiltrate of human metastatic melanomas. Activation by interleukin 2 and autologous tumor cells, and involvement of the T cell receptor.Journal of Experimental Medicine, 1988
- Significance of T4 or T8 Phenotype of Human Cytotoxic T-Lymphocyte Clones1986
- Perturbation of the T4 molecule transmits a negative signal to T cells.Journal of Experimental Medicine, 1985
- Therapy of disseminated murine leukemia with cyclophosphamide and immune Lyt-1+,2- T cells. Tumor eradication does not require participation of cytotoxic T cells.Journal of Experimental Medicine, 1985
- Acquisition of specific cytotoxic activity by human T4+ T lymphocytes in cultureNature, 1984
- Clonal analysis of human cytotoxic T lymphocytes: T4+ and T8+ effector T cells recognize products of different major histocompatibility complex regions.Proceedings of the National Academy of Sciences, 1982